Ivermectin Pädia Gmbh

Ivermectin, the active ingredient in Ivermectin Pädia Gmbh, is an antiparasitic (macrocyclic lactone) presented as an oral formulation for systemic use. It is employed to treat a range of helminthic and ectoparasitic infections in both adults and children. GNH USA supplies Ivermectin Pädia Gmbh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivermectin acts on a variety of parasitic diseases by targeting the organisms' nervous system. - Strongyloidiasis: eliminates intestinal larvae and prevents autoinfection. - Onchocerciasis: kills microfilariae, reducing skin and ocular manifestations. - Scabies: eradicates Sarcoptes mites, relieving itching and skin lesions. - Lymphatic filariasis: reduces microfilarial load, helping to control transmission.

Ivermectin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools occurring shortly after dosing. - Abdominal pain: cramp‑like discomfort.

Serious or Rare Side Effects: - Severe skin reactions: including Stevens‑Johnson syndrome. - Hepatic injury: elevated liver enzymes or jaundice. - Visual disturbances: blurred vision or ocular pain. - Seizures: rare neurologic events, especially in patients with CNS disorders. - Anaphylaxis: acute allergic reaction requiring immediate medical attention.

Before prescribing Ivermectin, clinicians should consider several safety measures. - Contraindications: avoid in patients with known hypersensitivity to ivermectin or its excipients. - Liver function: monitor hepatic enzymes in patients with pre‑existing liver disease. - Central nervous system disorders: use cautiously in patients with a history of seizures or encephalopathy. - Drug interactions: review concomitant medications that may affect ivermectin metabolism. - Storage: Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ivermectin may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin): may reduce ivermectin plasma concentrations. - Warfarin: concurrent use can increase bleeding risk. - Neurotoxic agents (e.g., levetiracetam): may potentiate neurotoxicity.

Moderate Interactions (Monitor Closely): - P‑gp inhibitors (e.g., verapamil): may raise ivermectin levels. - Other antiparasitics: combined use can increase the frequency of adverse gastrointestinal effects.